Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.237 USD | +2.12% | -1.90% | -34.60% |
May. 06 | Genenta Science S.p.A. Announces New Board Appointments | CI |
Apr. 08 | Genenta Science S.P.A. Announces Resignation of Board Members | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 55.36M 59.24M |
---|---|---|---|---|---|
Net income 2024 * | -18M -19.26M | Net income 2025 * | -24M -25.69M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.6
x | P/E ratio 2025 * |
-3.4
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.08% |
1 day | +2.12% | ||
1 week | -1.90% | ||
Current month | +1.48% | ||
1 month | +0.54% | ||
3 months | -19.07% | ||
6 months | -38.34% | ||
Current year | -34.60% |
Managers | Title | Age | Since |
---|---|---|---|
Bernhard Gentner
FOU | Founder | - | 14-07-23 |
Luigi Naldini
FOU | Founder | - | 14-07-23 |
Chief Executive Officer | 50 | 14-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 62 | 21-05-19 |
Roger Abravanel
BRD | Director/Board Member | 77 | 21-05-19 |
Chief Executive Officer | 50 | 14-07-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 3.237 | +2.12% | 453 |
24-06-13 | 3.17 | +0.63% | 117 |
24-06-12 | 3.15 | -4.55% | 1,125 |
24-06-11 | 3.3 | 0.00% | 1,203 |
24-06-10 | 3.3 | 0.00% | 464 |
Delayed Quote Nasdaq, June 14, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.60% | 59.21M | |
+40.80% | 53.67B | |
-8.05% | 38.76B | |
+35.79% | 38.86B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- GNTA Stock